This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Shift In Revenue Recognition From Q3 To Q4 Decreases RADCOM's Q3 Revenues To $3.4M

Risks Regarding Forward-Looking Statements

Certain statements made herein that use words such as "estimate," "project," "intend," "expect," "'believe", "may", "might", "predict", "potential", "anticipate", "plan" or similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties that could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied by such statements, including, among others, changes in general economic and business conditions and specifically, decline in the demand for the Company's products, inability to timely develop and introduce new technologies, products and applications, and loss of market share and pressure on prices resulting from competition. For additional information regarding these and other risks and uncertainties associated with the Company's business, reference is made to the Company's reports filed from time to time with the United States Securities and Exchange Commission. The Company does not undertake to revise or update any forward-looking statements for any reason.
                  Consolidated Statements of Operations
        (1000's of U.S. dollars, except share and per share data)
                     Three months ended              Nine months ended
                        September 30,                   September 30,
                       2011           2010         2011               2010
                   (unaudited)     (unaudited)  (unaudited)       (unaudited)
    Sales             $ 3,449        $ 4,812     $ 14,983           $ 13,810
    Cost of sales       1,366          1,573        4,570              4,585
    Gross profit        2,083          3,239       10,413              9,225
    Research and 
    development, gross  1,457          1,114        4,332              3,199
    Less - 
    participation         257            380        1,006              1,141
    Research and 
    development, net    1,200            734        3,326              2,058
    Sales and marketing 2,346          1,827        7,246              4,923
    General and 
    administrative (1)    520            358        1,721                991
    Total operating 
    expenses            4,066          2,919       12,293              7,972
    Operating income 
    (loss)             (1,983)           320      (1,880)              1,253
    Financing income 
    (expenses), net      (186)            41         (88)               (761)
    Net income (loss)  (2,169)           361      (1,968)                492
    Basic net income 
    (loss) per ordinary
    share             $ (0.34)        $ 0.07     $ (0.31)             $ 0.10
    Diluted net income 
    (loss) per ordinary 
    share             $ (0.34)        $ 0.06     $ (0.31)             $ 0.09
    Weighted average 
    number of
    ordinary shares 
    used in
    computing basic 
    net income
    (loss) per 
    ordinary share  6,373,675      5,218,847   6,357,003           5,145,651
    Weighted average 
    number of
    ordinary shares 
    used in
    computing diluted 
    net income
    (loss) per 
    ordinary share  6,373,675      5,837,570   6,357,003           5,594,547

(1) Includes a decrease of $120,000 in allowance for doubtful accounts for the three month period ended September 30, 2010, and a decrease of $326,000 in allowance for doubtful accounts for the nine month period ended September 30, 2010.



3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs